Otros idiomas Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE

Acciones

TEVA

IL0006290147

Diferido TEL AVIV STOCK EXCHANGE Otros sitios de cotización 09:57:08 02/06/2024			Varia. Cinco días.	Varia. 1 de enero.
6.291 ^ILa	+2,46 %		+3,00 %	+64,74 %

30/05	Teva Pharmaceutical obtiene la aprobacion de la FDA para una pildora diaria contra la enfermedad de Huntington	MT
30/05	Teva Pharmaceutical Industries Limited anuncia que los comprimidos de liberación prolongada de AUSTEDO® XR (deutetrabenazina) ya están aprobados por la FDA de EE.UU. como opción de tratamiento de un solo comprimido una vez al día para dosis clínicamente terapéuticas (24?48 mg/día)	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill	30/05
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)	30/05
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	21/05
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	17/05
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	15/05
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	15/05
Transcript : Teva Pharmaceutical Industries Limited Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	14/05
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Piper Sandler optimiste sur le dossier	13/05
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	08/05
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	08/05
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	08/05
Sector Update: Health Care	08/05
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	08/05
Transcript : Teva Pharmaceutical Industries Limited, Q1 2024 Earnings Call, May 08, 2024	08/05
Teva Pharm Q1 profit falls short of estimates, revenue gains	08/05
Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024	08/05
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Titulares

Teva Pharmaceutical Industries Limited : Aún debe relajarse

01 de febrero 2024 a las 11:04

ENTREVISTA - Richard Francis, Consejero Delegado de Teva Pharmaceutical: buen trimestre, aumento de las previsiones anuales

02 de agosto 2023 a las 21:19